Home  |  Contact

UniProtKB/Swiss-Prot Q9BXW9: Variant p.Pro714Leu

Fanconi anemia group D2 protein
Gene: FANCD2
Variant information

Variant position:  714
The position of the amino-acid change on the UniProtKB canonical protein sequence.

Type of variant:  Polymorphism
The variants are classified into three categories: Disease, Polymorphism and Unclassified.
  • Disease: Variants implicated in disease according to literature reports.
  • Polymorphism: Variants not reported to be implicated in disease.
  • Unclassified: Variants with uncertain implication in disease according to literature reports. Evidence against or in favor of a pathogenic role is limited and/or conflicting.

Residue change:  From Proline (P) to Leucine (L) at position 714 (P714L, p.Pro714Leu).
Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.

Physico-chemical properties:  Similar physico-chemical property. Both residues are medium size and hydrophobic.
The physico-chemical property of the reference and variant residues and the change implicated.

BLOSUM score:  -3
The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page

Variant description:  Common polymorphism.
Any additional useful information about the variant.

Other resources:  
Links to websites of interest for the variant.



Sequence information

Variant position:  714
The position of the amino-acid change on the UniProtKB canonical protein sequence.

Protein sequence length:  1451
The length of the canonical sequence.

Location on the sequence:   GIAINLLPLLFSQDFAKDGG  P VTSQESGQKLVSPLCLAPYF
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.

Residue conservation: 
The multiple alignment of the region surrounding the variant against various orthologous sequences.

Human                         GIAINLLPLLFSQDFAKDGGPVTSQESGQKLVSPLCLAPYF

Mouse                         GIVINLLPLFY-QECAKDASRATSQESSQRSMSSLCLASHF

Rat                           GIVINLLPLFF-QEFAKDVSQVTSQESSQKSMSPLCLASHF

Sequence annotation in neighborhood:  
The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.

TypePositionsDescription
Chain 1 – 1451 Fanconi anemia group D2 protein
Modified residue 717 – 717 Phosphoserine
Alternative sequence 242 – 1451 Missing. In isoform 4.


Literature citations

Positional cloning of a novel Fanconi anemia gene, FANCD2.
Timmers C.; Taniguchi T.; Hejna J.; Reifsteck C.; Lucas L.; Bruun D.; Thayer M.; Cox B.; Olson S.; D'Andrea A.D.; Moses R.; Grompe M.;
Mol. Cell 7:241-248(2001)
Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (ISOFORMS 1 AND 2); FUNCTION; TISSUE SPECIFICITY; VARIANTS FANCD2 TRP-302 AND HIS-1236; VARIANT LEU-714;

Submission
NIEHS SNPs program;
Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA]; VARIANTS ARG-33; MET-61; HIS-65; MET-172; ALA-193; GLN-328; VAL-446; ARG-456; PRO-623; LEU-714; ARG-865 AND VAL-901;

Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis.
Olsen J.V.; Vermeulen M.; Santamaria A.; Kumar C.; Miller M.L.; Jensen L.J.; Gnad F.; Cox J.; Jensen T.S.; Nigg E.A.; Brunak S.; Mann M.;
Sci. Signal. 3:RA3-RA3(2010)
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-8; SER-594; SER-717; SER-1412; SER-1423; THR-1426 AND SER-1435; VARIANT [LARGE SCALE ANALYSIS] LEU-714; IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS];

Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.